VCF — Class II drug recall D-0151-2025
Ongoing recall by Apothecus Pharmaceutical Corp., reported 2024-12-25, distributed nationwide. CGMP deviations: out of specifications for assay
| Recall number | D-0151-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apothecus Pharmaceutical Corp., Hicksville, NY, United States |
| Recall initiated | 2024-11-22 |
| Classified | 2024-12-17 |
| Reported by FDA | 2024-12-25 |
| Distributed | Nationwide (US) |
| Countries outside the US | HK |
| Quantity | 33,659 retail |
| Reason classes | potency, cgmp, specification failure |
| NDC | 52925-0512, 52925-0512-10, 52925-0512-25 |
| Lot numbers | 07/25, 3A001/3A001A |
Product
VCF, Vaginal Contraceptive Gel, Birth Control, 10 Pre-filled Applicators, Net Wt. 0.09 oz (2.55g) Each, Distributed By: Apothecus Pharmaceutical Corp., Ronkonkoma, NY 11779, NDC 52925-512-10
Reason for recall
CGMP deviations: out of specifications for assay
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0151-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.